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The extracellular signal-regulated protein kinase (ERK), a subfamily of Mitogen-Activated Protein Kinase 
(MAPK) pathways, is one of the most important signals in the regulation of many biological processes. 
Deregulated of MAPK signaling pathways has been observed in human cancers with potential involvement in 
most of all cellular processes leading to tumorigenesis so that it became a potential target for therapy in 
cancer patients. In this paper, we discuss a Mathematical model of ERK activation in the presence of a small 
molecule inhibitor that competes with RAS. We present analytical expressions for the concentration of RAS, 
complex RAS-ERK, complex RAS-Inhibitor, and activated ERK in terms of dimensionless parameters using 
He’s Homotopy Perturbation Method (HPM). The analytical results are compared with numerical simulation 
and satisfactory agreement is obtained.  
KEYWORDS 
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1. INTRODUCTION 
MAPK pathways activated by growth and stress signals as well as 
cytokines by way of cell receptors such as tyrosine kinase receptors 
(RTKs) and G-protein coupled receptors (GCPR) (Dhillon et al., 2007). The 
MAPK signaling pathway is vital in regulating many cellular processes, 
including inflammation, cell stress response, differentiation, division, 
proliferation, metabolism, and apoptosis. The known major MAPK 
cascades distinguished by four distinct cascades, including the 
extracellular signal-related kinases (ERK1/2), Jun amino-terminal kinases 
(JNK1/2/3), p38-MAPK and ERK5. Activation of these pathways is started 
by ligand binding to receptor tyrosine kinases (RTK) at the cell surface and 
via Ras, Raf, MEK (mitogen-activated protein kinase), culminates in the 
regulation of gene transcription in the nucleus by the last pathway 
component, extracellular signal-regulated kinase (ERK) (Knight and 
Irving, 2014).  
The RAS/ERK pathway is activated by the adaptor protein Grb2 that 
recruited to the tyrosine phosphorylated ErbB1 through its Src homology 
2 (SH2) domain. Grb2 then brings in the guanyl nucleotide-release protein 
SOS to the plasma membrane by Grb2 binding to SOS through its Src 
homology 3 (SH3) domain. The mitogen-activated protein kinase kinase 
kinase (MKKK) RAF then binds to the activated RAS. This activates RAF, 
which leads to the phosphorylation of the mitogen-activated protein 
kinase kinase (MKK) MEK1/2 following activates the mitogen-activated 
protein kinase (MAPK) ERK1/2 through phosphorylation. This leads to the 
activation of a variety of ERK1/2 downstream signaling pathways, 
including transcription factors, and ultimately to increased proliferation 
and cell survival (Henson and Gibson, 2010). 
The RAS/ERK pathways are frequently deregulated in human cancers as a 
result of abnormal activation of receptor tyrosine kinases or gain-of-
function mutations, mainly in the RAS or RAF genes. The deregulated 
activation of the RAS/ERK pathway has been reported in many types of 
carcinomas that affect the skin breasts, pancreas, liver, and the thyroid, 
respectively (Santarpia et al., 2012; Cseh et al., 2014; Wellbrock and 
Arozarena, 2016). In this paper, we focus on the RAS/ERK pathway as an 
application example for the proposed modeling approach. The 
deregulated activation of the Ras-ERK pathway includes overexpression 
of cell membrane receptors and ligands, mutations of receptors and 
signaling proteins, and the sustained ligand-receptor stimuli mediated by 
autocrine or paracrine means. This understanding of the RAS-ERK 
signaling pathway inspired various therapeutic approaches focused on 
drug-mediated inhibition of the mutant RAS-RAF axis, respected to be the 
key driver of the deregulated activation of ERK. Unfortunately, this target 
inhibition is deflected by cancerous cells through the activation of the 
PI3K-mTOR pathway, whose deregulated control of cell growth and 
survival coexist with that of the Ras-ERK signaling pathway for many of 
cancers (Derbal, 2014). 
Mathematical modeling of biopathways with molecule inhibition have 
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studied (Adi et al., 2016). The other model of the MAPK pathway also has 
been conducted in (Derbal, 2014; Pappalardo et al., 2016). In this paper, 
we develop a Mathematical model of ERK activation in the presence of a 
small molecule inhibitor that competes with RAS. Several papers have 
studied the modeling of some nonlinear problems in enzyme kinetics and 
provide an analytical solution by using the Homotopy Perturbation 
Method (HPM) (Varadharajan and  Rajendran, 2011; Sivasamy et al., 
2016). Recently presented the use of HPM to give an analytical 
approximate solution of the nonlinear problem (Haq, 2019). Now, HPM 
has been widely used to solving numerous problems of the nonlinear 
system because of its rapid convergence (Sinan, 2020). In this paper, we 
use the HPM methods in ERK activation under the condition that the initial 
ERK concentration is much smaller than the initial concentration of the 
RAS, 
0 0s e . The purpose of this works is to present analytical 
expressions for the concentration of ERK, complex RAS-ERK, complex 
RAS-Inhibitor, and activated ERK in terms of dimensionless parameters. 
We also offer a comparative study of the same with numerical simulation 
by using Runge Kutta fourth order (RK). 
2. MODEL DEVELOPMENT 
In this model, we assume that a small molecule inhibitor act as a 
competitive inhibitor that mimics ERK but doesn’t undergo a reaction. We 
then follow Ingalls in modeling reaction enzyme subtract in presence 
competitive inhibitor (Ingalls, 2013). The formulation of biochemical 
reaction considers a reaction where 𝐸𝑅𝐾 as a substrate bind 𝑅𝐴𝑆 as an 
enzyme to form a complex 𝑅𝐴𝑆: 𝐸𝑅𝐾. The Inhibitor is structurally similar 
to the substrate so that it competes for the active site by developing a 





















da ,  and 
i
k  is the rate of association, dissociation, and activation 
of protein assumed to be constant. 
In order to describe the mathematical model of the biochemical reaction 
above, we use the law of mass action in an ordinary differential equations 
(ODE) system. Let us define states of the system; == ][ERKs
concentration of ERK, == ][RASe the concentration of RAS, 
== ERKRASc :[ the concentration of RAS:ERK complex, == ][ERKap
the concentration of activated ERK, == ][Ii the concentration of 
inhibitor, == ]:[ IRASc
I
concentration of RAS-Inhibitor complex.  
With the law of mass action and quasi-steady-state assumption, the 
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The system of equations (1)- (4) with initial conditions (5) can be 
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with initial conditions 
0)0(,0)0(,0)0(,1)0( ==== zwvu    (10) 
3. ANALYTICAL SOLUTION OF STEADY STATE CONCENTRATION
USING HPM 
To find the analytical expressions for the concentration of 𝐸𝑅𝐾, 𝑅𝐴𝑆: 𝐸𝑅𝐾 
complex, 𝑅𝐴𝑆: 𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑜𝑟 complex, and 𝐸𝑅𝐾𝑎 , we first construct a 
homotopy to determine the solution of equation (6)-(8) as follows: 
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with the initial conditions are as follows: 
0)0(,0)0(,1)0( === wvu   (14) 
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After substituting equations (15), (16), and (17) into equations (11), (12), 
and (13) respectively, and comparing the coefficient of like powers of p we 
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Solving (18)-(26) using initial conditions (14) and according to HPM, we 
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)()( dvz    (30) 
Equatian (30) is easy to solve, represent the product 𝑧(𝜏) for all values 
parameters given in equation (28). 
4. RESULT AND DISCUSSION 
The concentration of  𝑅𝐴𝑆, complex 𝑅𝐴𝑆 − 𝑅𝐴𝐹, complex  𝑅𝐴𝐹: Inhibitor, 
and Activated ERK versus time is plotted in Figure 2 using (27) - (30). The 
nonlinear ODE system (1) - (4) with initial condition (5) is also solved 
using numerical methods. The numerical method is done by using the 
Runge-Kutta fourth order with Ode45, one of differential solvers in Matlab. 
Figure 1 shows the numerical result, and we have a good agreement with 
analytical expression using HPM in Figure 2. It is observed that the 
dimensionless 𝑅𝐴𝑆 concentration, u and complex 𝑅𝐴𝑆: 𝑅𝐴𝐹, 𝑣 decreases 
gradually from its initial value and becomes zero. It is also observed that 
the concentration ERK, 𝑧 and complex IRAS:  w  increases. This 
simulation result alsoggests that ERK is a potential target for improving 
the success of molecular therapy. We also give comparation these two 
methods in Figures 3 - 6 for various values of dimensionless parameters 
 . 
Figure 1: Plot of dimensionless concentration of ERK, complex RAS-ERK, 
complex RAS-Inhibitor, and ERKa numerically using Runge Kutta fourth-
order (RK) parameter value 10 = ,
1 0.5 = , 2 2 = , 3 0.2 = , 4 0.7 = ,
5 0.2 = .
Figure 2: Plot of dimensionless concentration of ERK, complex RAS-ERK, 
complex RAS-Inhibitor, and ERKa using HPM with  parameter value 
10 = ,
1 0.5 = , 2 2 = , 3 0.2 = , 4 0.7 = , 5 0.2 = .
Figure 3: The concentration of dimensionless ERK ( u ) using HPM 
)( −−  and  RK (--) for various values of dimensionless parameters  . 
Figure 4: The concentration of dimensionless complex 𝑅𝐴𝑆: 𝐸𝑅𝐾 (𝑣) 
using HPM )( −−   and RK (--) for various values of dimensionless 
parameters . 
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Figure 5: The concentration of dimensionless complex RAS-Inhibitor (
w ) using HPM )( −−  and RK (--) for various values of dimensionless 
parameters  . 
Figure 6: The concentration of dimensionless ERKa ( z ) using HPM 
)( −−  and RK (--) for various values of dimensionless parameters  . 
From Figures 3 – 6, it is infered that if the initial concentration of ERK is 
getting smaller than the contentration of RAS, indicated with the increase 
value of the dimensionless parameter  ,  HPM provide rapid and fast 
convergence. 
5. CONCLUSION 
In this paper, an analytical expression of ERK, complex 𝑅𝐴𝑆: 𝐸𝑅𝐾, complex 
RAS:Inhibitor and 𝐸𝑅𝐾𝑎 in terms of dimensionless parameters are derived 
using He’s Homotopy Perturbation Method (HPM). The HPM compared 
with numerical solutions method, i.e. Runge Kutta fourth-order. We 
compared both types of solutions graphically and observed that the 
solution gets closer to each other. This result suggests that the HPM gives 
a very accurate approximation to the solution of our model under the 
assumption that the initial concentration of RAS is higher than the initial 
concentration of ERK. 
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